Korean Journal of Radiology

  • 제12권2호
  • /
  • Pages.203-209
  • /
  • 2011
  • /
  • 1229-6929(pISSN)
  • /
  • 2005-8330(eISSN)
대한영상의학회 (The Korean Society of Radiology)
권호 표지
DOI QR코드

DOI QR Code

The Primary Patency and Fracture Rates of Self-Expandable Nitinol Stents Placed in the Popliteal Arteries, Especially in the P2 and P3 Segments, in Korean Patients

  • Chang, Il-Soo (Department of Radiology, Konkuk University Hospital) ;
  • Chee, Hyun-Keun (Department of Thoracic and Cardiovascular Surgery, Konkuk University Hospital) ;
  • Park, Sang-Woo (Department of Radiology, Konkuk University Hospital) ;
  • Yun, Ik-Jin (Department of Surgery, Konkuk University Hospital) ;
  • Hwang, Jae-Joon (Department of Thoracic and Cardiovascular Surgery, Konkuk University Hospital) ;
  • Lee, Song-Am (Department of Thoracic and Cardiovascular Surgery, Konkuk University Hospital) ;
  • Kim, Jun-Seok (Department of Thoracic and Cardiovascular Surgery, Konkuk University Hospital) ;
  • Chang, Seong-Hwan (Department of Surgery, Konkuk University Hospital) ;
  • Jung, Hong-Geun (Department of Orthopedic Surgery, Konkuk University Hospital)
  • 발행 : 2011.04.01
⟨ 이전 논문 다음 논문 ⟩

초록

Objective: We wanted to evaluate the status of self-expandable nitinol stents implanted in the P2 and P3 segments of the popliteal artery in Korean patients. Materials and Methods: We retrospectively analyzed 189 consecutive patients who underwent endovascular treatment for stenoocclusive lesions in the femoropopliteal artery from July 2003 to March 2009, and 18 patients who underwent stent placement in popliteal arterial P2 and P3 segments were finally enrolled. Lesion patency was evaluated by ultrasound or CT angiography, and stent fracture was assessed by plain X-rays at 1, 3, 6 and 12 months and annually thereafter. Results: At the 1-month follow-up, stent fracture (Type 2) was seen in one limb (up to P3, 1 of 18, 6%) and it was identified in seven limbs at the 3-month follow-up (Type 2, Type 3, Type 4) (n = 1: up to P2; n = 6: P3). At the 6-month follow-up, one more fracture (Type 1) (up to P3) was noted. At the 1-year follow-up, there were no additional stent fractures. Just four limbs (up to P2) at the 2-year follow-up did not have stent fracture. The primary patency was 94%, 61% and 44% at 1, 3 and 6 months, respectively, and the group with stent implantation up to P3 had a higher fracture rate than that of the group that underwent stenting up to P2 (p < 0.05). Conclusion: We suggest that stent placement up to the popliteal arterial P3 segment and over P2 in an Asian population can worsen the stent patency owing to stent fracture. It may be necessary to develop a stent design and structure for the Asian population that can resist the bending force in the knee joint.

키워드

참고문헌

  1. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31:S1-S296 https://doi.org/10.1016/S0741-5214(00)81002-2
  2. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-society consensus for the management of peripheral arterial disease. Int Angiol 2007;26:81-157
  3. Cejna M, Thurnher S, Illiasch H, Horvath W, Waldenberger P, Hornik K, et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol 2001;12:23-31 https://doi.org/10.1016/S1051-0443(07)61397-9
  4. Conroy RM, Gordon IL, Tobis JM, Hiro T, Kasaoka S, Stemmer EA, et al. Angioplasty and stent placement in chronic occlusion of the superficial femoral artery: technique and results. J Vasc Interv Radiol 2000;11:1009-1020 https://doi.org/10.1016/S1051-0443(07)61331-1
  5. Gordon IL, Conroy RM, Arefi M, Tobis JM, Stemmer EA, Wilson SE. Three-year outcome of endovascular treatment of superficial femoral artery occlusion. Arch Surg 2001;136:221- 228 https://doi.org/10.1001/archsurg.136.2.221
  6. Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology 1992;183:767-771 https://doi.org/10.1148/radiology.183.3.1294068
  7. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al. Balloon angioplasty versus implantation of nitinol stents in the superfi cial femoral artery. N Engl J Med 2006;354:1879-1888 https://doi.org/10.1056/NEJMoa051303
  8. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, et al. Sustained benefi t at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007;115:2745-2749 https://doi.org/10.1161/CIRCULATIONAHA.107.688341
  9. Sabeti S, Schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R, et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology 2004;232:516-521 https://doi.org/10.1148/radiol.2322031345
  10. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 2005;16:331-338 https://doi.org/10.1097/01.RVI.0000151260.74519.CA
  11. Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 2002;106:1505-1509 https://doi.org/10.1161/01.CIR.0000029746.10018.36
  12. Scheinert D, Scheinert S, Sax J, Piorkowski C, Braunlich S, Ulrich M, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312-315 https://doi.org/10.1016/j.jacc.2004.11.026
  13. Sabeti S, Mlekusch W, Amighi J, Minar E, Schillinger M. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther 2005;12:6-12 https://doi.org/10.1583/04-1359.1
  14. Strecker EP, Boos IB, Gottmann D, Vetter S, Haase W. Popliteal artery stenting using flexible tantalum stents. Cardiovasc Intervent Radiol 2001;24:168-175 https://doi.org/10.1007/s002700002526
  15. Rocha-Singh KJ, Jaff MR, Crabtree TR, Bloch DA, Ansel G. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv 2007;69:910-919 https://doi.org/10.1002/ccd.21104
  16. Costanza MJ, Queral LA, Lilly MP, Finn WR. Hemodynamic outcome of endovascular therapy for Trans Atlantic Inter Society Consensus type B femoropopliteal arterial occlusive lesions. J Vasc Surg 2004;39:343-350 https://doi.org/10.1016/j.jvs.2003.07.007
  17. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005;366:1925-1934 https://doi.org/10.1016/S0140-6736(05)67704-5
  18. Gray BH, Sullivan TM, Childs MB, Young JR, Olin JW. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg 1997;25:74-83 https://doi.org/10.1016/S0741-5214(97)70323-9
  19. Surowiec SM, Davies MG, Eberly SW, Rhodes JM, Illig KA, Shortell CK, et al. Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg 2005;41:269-278 https://doi.org/10.1016/j.jvs.2004.11.031
  20. van der Zaag ES, Legemate DA, Prins MH, Reekers JA, Jacobs MJ. Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial. Eur J Vasc Endovasc Surg 2004;28:132-137 https://doi.org/10.1016/j.ejvs.2004.04.003
  21. Smouse HB, Nikanorov A, LaFlash D. Biomechanical forces in the femoropopliteal arterial segment. What happens during extremity movement and what is the effect on stenting? Endovasc Today 2005;4:60-66
  22. Allie DE, Hebert CJ, Walker CM. Pressure-sensing guidewire analysis in RAS. Adapting this coronary-based technology to optimise "functional" renal artery revascularization could have signifi cant clinical implications. Endovasc Today 2004;1:14-26
  23. Iida O, Nanto S, Uematsu M, Morozumi T, Kotani J, Awata M, et al. Effect of exercise on frequency of stent fracture in the superficial femoral artery. Am J Cardiol 2006;98:272-274 https://doi.org/10.1016/j.amjcard.2006.01.091
  24. Iida O, Nanto S, Uematsu M, Ikeoka K, Okamoto S, Nagata S. Influence of stent fracture on the long-term patency in the femoro-popliteal artery: experience of 4 years. JACC Cardiovasc Interv 2009;2:665-671 https://doi.org/10.1016/j.jcin.2009.04.014
  25. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45:S5- S67 https://doi.org/10.1016/j.jvs.2006.12.037

피인용 문헌

  1. Coronary and endovascular applications of the Absorb™ bioresorbable vascular scaffold vol.4, pp.6, 2011, https://doi.org/10.2217/ica.12.62
  2. Assessment of self-expanding nitinol stent deformation after chronic implantation into the femoropopliteal arteries. vol.9, pp.6, 2011, https://doi.org/10.4244/eijv9i6a117
  3. Endovascular Repair of Blunt Popliteal Arterial Injuries vol.17, pp.5, 2011, https://doi.org/10.3348/kjr.2016.17.5.789
  4. Is Open Vascular Surgery or Endovascular Surgery the Better Option for Lower Extremity Arterial Occlusive Disease? vol.51, pp.None, 2017, https://doi.org/10.1016/j.yasu.2017.03.016
  5. Incidence and Endovascular Treatment of Isolated Atherosclerotic Popliteal Artery Disease: Outcomes from the IPAD Multicenter Study vol.41, pp.10, 2011, https://doi.org/10.1007/s00270-018-2028-7
  6. Balloon Angioplasty Versus Bailout Stenting for Isolated Chronic Total Occlusions in the Popliteal Artery vol.53, pp.2, 2011, https://doi.org/10.1177/1538574418814060
  7. Different Vascular Responses to a Bare Nitinol Stent in Porcine Femoral and Femoropopliteal Arteries vol.47, pp.3, 2011, https://doi.org/10.1177/0192623318800726
  8. Mid-term results and predictors of restenosis in patients undergoing endovascular therapy for isolated popliteal artery steno-occlusive disease vol.13, pp.1, 2011, https://doi.org/10.1556/1647.2020.00010
  9. Mid-term results and predictors of restenosis in patients undergoing endovascular therapy for isolated popliteal artery steno-occlusive disease vol.13, pp.1, 2011, https://doi.org/10.1556/1647.2020.00010
  10. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: Midterm results vol.29, pp.5, 2021, https://doi.org/10.1177/1708538114568884